Page 1 | Search Results | Blood Advances | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Patients with triple-negative, JAK2 V617F- and CALR -mutated essential thrombocythemia share a unique gene expression signature

Blood Adv (2021) 5 (4): 1059–1068.

https://doi.org/10.1182/bloodadvances.2020003172

Published: 2021

Includes: Supplemental data

Journal Articles

RAS / CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features

Giacomo Coltro, Giada Rotunno, Lara Mannelli, Carmela Mannarelli, Sara Fiaccabrino, Simone Romagnoli, Niccolò Bartalucci, Enrica Ravenda, Eleonora Gelli, Emanuela Sant’Antonio, Mrinal M. Patnaik, Ayalew Tefferi, Alessandro M. Vannucchi, Paola Guglielmelli

Blood Adv (2020) 4 (15): 3677–3687.

https://doi.org/10.1182/bloodadvances.2020002175

Published: 2020

Includes: Supplemental data

Journal Articles

Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model

Nitza Vara, Yuqing Liu, Yan Yan, Shelly Y. Lensing, Natalia Colorado, Delli Robinson, Jingliao Zhang, Xin Zhang, Erich A. Peterson, Nicholas J. Baltz, Daohong Zhou, Alice Bertaina, Donald J. Johann, Jr, Peter D. Emanuel, Y. Lucy Liu

Blood Adv (2020) 4 (15): 3728–3740.

https://doi.org/10.1182/bloodadvances.2020002326

Published: 2020

Includes: Supplemental data

Journal Articles

Circulating CD1c + myeloid dendritic cells are potential precursors to LCH lesion CD1a + CD207 + cells

Blood Adv (2020) 4 (1): 87–99.

https://doi.org/10.1182/bloodadvances.2019000488

Published: 2020

Includes: Supplemental data

Journal Articles

Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma

Yu-Hsiu T. Lin, Gregory P. Way, Benjamin G. Barwick, Margarette C. Mariano, Makeba Marcoulis, Ian D. Ferguson, Christoph Driessen, Lawrence H. Boise, Casey S. Greene, Arun P. Wiita

Blood Adv (2019) 3 (21): 3214–3227.

https://doi.org/10.1182/bloodadvances.2019000303

Published: 2019

Includes: Supplemental data

Journal Articles

Acute myeloid leukemia–induced T-cell suppression can be reversed by inhibition of the MAPK pathway

Kaycee B. Moshofsky, Hyun J. Cho, Guanming Wu, Kyle A. Romine, Matthew T. Newman, Yoko Kosaka, Shannon K. McWeeney, Evan F. Lind

Blood Adv (2019) 3 (20): 3038–3051.

https://doi.org/10.1182/bloodadvances.2019000574

Published: 2019

Journal Articles

A scale for patient-reported symptom assessment for patients with Erdheim-Chester disease

Eli L. Diamond, Anne S. Reiner, Justin J. Buthorn, Elyse Shuk, Allison J. Applebaum, David M. Hyman, Omar Abdel-Wahab, Raajit Rampal, Filip Janku, Kathleen Brewer, Jean Campbell, Jun J. Mao, Thomas M. Atkinson, Katherine S. Panageas

Blood Adv (2019) 3 (7): 934–938.

https://doi.org/10.1182/bloodadvances.2018030502

Published: 2019

Journal Articles

Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo

Moua Yang, Andaleb Kholmukhamedov, Marie L. Schulte, Brian C. Cooley, Na’il O. Scoggins, Jeremy P. Wood, Scott J. Cameron, Craig N. Morrell, Shawn M. Jobe, Roy L. Silverstein

Blood Adv (2018) 2 (21): 2848–2861.

https://doi.org/10.1182/bloodadvances.2018025411

Published: 2018

Includes: Multimedia, Supplemental data

Journal Articles

The lipid peroxidation product 4-hydroxy-2-nonenal induces tissue factor decryption via ROS generation and the thioredoxin system

Shabbir A. Ansari, Usha R. Pendurthi, L. Vijaya Mohan Rao

Blood Adv (2017) 1 (25): 2399–2413.

https://doi.org/10.1182/bloodadvances.2017010132

Published: 2017

Includes: Supplemental data

Journal Articles

BRAF V600E accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemia

Yo-Ting Tsai, Aparna Lakshmanan, Amy Lehman, Bonnie K. Harrington, Fabienne McClanahan Lucas, Minh Tran, Ellen J. Sass, Meixiao Long, Alan D. Flechtner, Florinda Jaynes, Krista La Perle, Vincenzo Coppola, Gerard Lozanski, Natarajan Muthusamy, John C. Byrd, Michael R. Grever, David M. Lucas

Blood Adv (2017) 1 (24): 2147–2160.

https://doi.org/10.1182/bloodadvances.2017006593

Published: 2017

Includes: Supplemental data

Journal Articles

Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells

Mia Eriksson, Pablo Peña-Martínez, Ramprasad Ramakrishnan, Marion Chapellier, Carl Högberg, Gabriella Glowacki, Christina Orsmark-Pietras, Talía Velasco-Hernández, Vladimir Lj Lazarević, Gunnar Juliusson, Jörg Cammenga, James C. Mulloy, Johan Richter, Thoas Fioretos, Benjamin L. Ebert, Marcus Järås

Blood Adv (2017) 1 (23): 2046–2057.

https://doi.org/10.1182/bloodadvances.2017006148

Published: 2017

Includes: Supplemental data

Journal Articles

The clinical spectrum of Erdheim-Chester disease: an observational cohort study

Juvianee I. Estrada-Veras, Kevin J. O’Brien, Louisa C. Boyd, Rahul H. Dave, Benjamin H. Durham, Liqiang Xi, Ashkan A. Malayeri, Marcus Y. Chen, Pamela J. Gardner, Jhonell R. Alvarado Enriquez, Nikeith Shah, Omar Abdel-Wahab, Bernadette R. Gochuico, Mark Raffeld, Elaine S. Jaffe, William A. Gahl

Blood Adv (2017) 1 (6): 357–366.

https://doi.org/10.1182/bloodadvances.2016001784

Published: 2017

Includes: Supplemental data

Journal Articles

Targeted inhibition of the MAPK pathway: emerging salvage option for progressive life-threatening multisystem LCH

Alexandra Kolenová, Raphaela Schwentner, Gunhild Jug, Ingrid Simonitsch-Klupp, Christoph Kornauth, Lukáš Plank, Júlia Horáková, Ivana Bodová, Tomáš Sýkora, Lucia Geczová, Wolfgang Holter, Milen Minkov, Caroline Hutter

Blood Adv (2017) 1 (6): 352–356.

https://doi.org/10.1182/bloodadvances.2016003533

Published: 2017

Includes: Supplemental data

NARROW

Patients with triple-negative, JAK2 V617F- and CALR -mutated essential thrombocythemia share a unique gene expression signature

RAS / CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features

Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model

Circulating CD1c + myeloid dendritic cells are potential precursors to LCH lesion CD1a + CD207 + cells

Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma

Acute myeloid leukemia–induced T-cell suppression can be reversed by inhibition of the MAPK pathway

A scale for patient-reported symptom assessment for patients with Erdheim-Chester disease

Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo

The lipid peroxidation product 4-hydroxy-2-nonenal induces tissue factor decryption via ROS generation and the thioredoxin system

BRAF V600E accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemia

Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells

The clinical spectrum of Erdheim-Chester disease: an observational cohort study

Targeted inhibition of the MAPK pathway: emerging salvage option for progressive life-threatening multisystem LCH

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only